Avascular Necrosis of the Femoral Head Causes
Avascular Necrosis of the Femoral Head Causes
The cause of avascular necrosis is always the same event — the blood supply to the femoral head is interrupted — but the routes to that event are different, and the route matters, because some are changeable, some are treatable, and some are simply facts to plan around. In a large share of cases a cause is found; in the rest the disease is described as idiopathic, which means no cause was identified rather than that none exists. This page works through the routes, and then through the explanations patients most often arrive with that do not hold up.
Corticosteroids: the commonest identifiable cause
Steroid treatment is the most frequently identified cause, and the pattern is broader than most patients expect. It is not limited to long-term high-dose treatment: short courses at high dose, pulses given for an inflammatory flare or after a transplant, and long-term low-dose treatment for asthma, inflammatory bowel disease, rheumatoid disease or kidney disease all appear in the history of patients who develop the disease. There is no dose below which the risk disappears, which is why the honest advice is not "avoid steroids" but "make sure every course is necessary, documented and reviewed".
Two consequences follow for anyone who has had steroids and now has hip pain. The first is that the other hip carries the same risk — in steroid-associated cases both hips are involved in the majority of patients, so both are imaged. The second is that the interval between exposure and symptoms varies widely: some patients ache a few months after a course, others years later, and a course given long ago is no reason to exclude the diagnosis. What matters for a new groin pain is the cumulative exposure over the years, including the courses the patient no longer remembers as steroids.
Alcohol: dose and duration rather than a single evening
Sustained heavy alcohol use is the second commonest identifiable cause. The mechanism is not a single effect but several together: alcohol alters fat metabolism, increases the fat content of the marrow and the pressure inside the bone, changes blood flow and affects the cells that maintain and rebuild bone. The result is the same end point — an interruption of supply to a segment of the femoral head — reached more gradually than after an injury and more diffusely than after a single steroid course.
Two practical points are worth stating. The first is that the risk follows sustained intake rather than one period of excess: it is the pattern over years, not a memorable week, that patients are asked to describe honestly. The second is that alcohol-associated disease tends to involve more extensive and more often bilateral lesions, which is part of why it is treated with a lower threshold for imaging both hips. Reducing intake is the one lever in this condition entirely within the patient's control, and it changes the prospects of both a preserved hip and a future one.
Injury: when the timing is predictable
Physical interruption of the vessels that run along the neck of the femur is the clearest mechanism of all. A fractured neck of femur — particularly a displaced one — damages the blood supply to the head at the moment of injury, and the risk of the bone dying afterwards depends on the type of fracture and on how well its blood supply is restored. A hip dislocation, and surgery around the hip that disturbs the same vessels, can do the same. In this group the disease is not a surprise; it is an expected risk that is followed deliberately, with imaging at planned intervals rather than only if symptoms appear.
What trauma does not usually do is affect both hips. That distinction matters in the consultation, because a patient whose cause is a single injury does not need the lifelong surveillance the systemic causes require. The distinction is drawn from the history, before the decision not to image the other hip is made — which is why the first question in the assessment is about steroids and alcohol rather than about the injury alone.
Blood and clotting: sickle cell, clotting disorders, autoimmune disease
A group of blood-related conditions produces the same result by making the blood less able to pass freely through small vessels, or by damaging the vessel walls themselves. Sickle cell disease is the classic example: the abnormal haemoglobin makes red cells stiff and liable to block small vessels, so painful crises and avascular necrosis are part of the same underlying problem, and in this group avascular necrosis may be bilateral and may affect several joints. Clotting disorders and conditions that thicken the blood — including inherited thrombophilias, and in some women pregnancy — are also recognised routes.
Autoimmune disease such as systemic lupus erythematosus sits in a complicated position: the disease itself and the steroid treatment used to control it both contribute, and separating the two is often impossible. Rare inherited storage disorders such as Gaucher disease produce the same result through the accumulation of material within the marrow. When any of these conditions is present, two things change in the approach: the other hip, and sometimes other joints, are imaged systematically; and the management of the underlying disease and the treatment of the hip are coordinated rather than handled as two unrelated matters.
Other routes, and the group with no cause found
Several further causes appear less often and are looked for deliberately. Radiotherapy and chemotherapy damage bone and its blood supply in the treated region. Decompression sickness in divers and in compressed-air workers produces gas bubbles that obstruct small vessels; the bone lesions may appear years after the exposure. HIV infection and its treatment, and organ transplantation with the immunosuppression that follows, are both recognised associations. Abnormal lipid levels and disorders of fat metabolism are common enough to be worth testing for, partly because they are treatable.
What remains is the largest group after steroids and alcohol: patients in whom no cause is found, described as idiopathic. This is a diagnosis of exclusion rather than an explanation — it means the search found no route, and the search itself may be incomplete. It does not change the stage or the treatment, since both depend on the hip rather than on the cause; but it does mean the other hip still has to be watched, because whatever tendency affected the first may affect the second. It is also the reason the history is worth taking again at each visit: a course of steroids, or a clotting problem, sometimes surfaces only later.
What does not cause it
| The belief | What is actually the case |
|---|---|
| "It is an old person's disease, like arthritis" | It appears most often between the thirties and the fifties — decades earlier than the wear-and-tear disease — and in a younger patient a new groin pain is investigated sooner, not later, for exactly this reason |
| "It comes from lifting weights or running" | Ordinary exercise is not a cause of the disease; it is load that fails an already weakened segment, which is why activity is modified after the diagnosis rather than blamed for it |
| "A normal X-ray means nothing is wrong" | The radiograph is normal in the earliest stage — the stage at which treatment can still keep the hip; MRI is what makes the difference, and a normal film is a reason to scan rather than to relax |
| "Only one hip is affected, so there is nothing to worry about on the other side" | In the systemic causes — steroids, alcohol, sickle cell disease, clotting disorders — the other hip is involved in most patients and is often at an earlier, more treatable stage |
| "A low dose of steroids is safe, so no monitoring is needed" | There is no dose below which the risk disappears, and the interval between exposure and symptoms can be years; new hip pain after any steroid exposure is assessed on its own merits |
| "Once it starts, nothing can be done until the hip is replaced" | Before the surface collapses there are operations whose purpose is to keep the patient's own hip, and their results depend on how early they are used — which is why the interval from first symptom to MRI matters so much |
The pattern behind these beliefs is the same in each case: the disease is being read as a slower, older, less urgent version of arthritis, when its defining feature is speed. The other pages of this guide take that difference further — how it is confirmed and staged, and what each treatment changes.
What knowing the cause changes
The list above is not academic. Which route applies to your hip decides four things: whether the other hip is imaged and how closely it is watched; whether the exposure can be reduced, as with alcohol or with steroid treatment reviewed alongside the prescribing doctor; whether an underlying condition such as a clotting disorder, abnormal lipids, sickle cell disease or lupus needs treatment in its own right; and how the prospects of a preservation operation are judged, since a hip still under pressure from its cause behaves differently from one whose cause has been removed. Establishing the route is part of staging the disease, not a separate enquiry — and where no route is found, the surveillance continues as if one existed.